Breaking News, Promotions & Moves

Innoforce Names Dewan Zeng CEO

Zeng previously served as lead for 20 clinical-stage assets at CV Therapeutics, Gilead, and Pfizer.

Zhejiang Innoforce Pharmaceuticals Co., Ltd., a CDMO that provides services for advanced therapy medicinal product (ATMP), appointed Dewan Zeng Chief Executive Officer, effective immediately. Yuling Li will continue to focus on technology innovation and CDMO operations as President. Zeng is an internationally recognized pharmaceutical product and business development leader. She has successfully leveraged her technical insights and leadership skills to foster organizational growth in several ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters